Clinical Edge Journal Scan

Clinical Edge Journal Scan

Preapheresis bendamustine worsens CAR T-cell therapy outcomes in relapsed or refractory LBCL

Publish date: November 15, 2023

• Read More

Clinical Edge Journal Scan

Commentary: Recent Practice-Changing Studies in LBCL and MCL, November 2023

Publish date: November 1, 2023

• Read More

Clinical Edge Journal Scan

Long-term exposure to trihalomethanes in drinking and swimming pool water increases the risk for CLL

Publish date: October 22, 2023

• Read More

Clinical Edge Journal Scan

CAR T-cell therapy safe for older patients with relapsed or refractory DLBCL

Publish date: October 22, 2023

• Read More

Clinical Edge Journal Scan

Acalabrutinib and zanubrutinib have similar efficacy in CLL, shows a matching-adjusted indirect comparison

Publish date: October 22, 2023

• Read More

Clinical Edge Journal Scan

Upfront ASCT overcomes the survival advantage provided by pre-transplant HDAC induction in MCL

Publish date: October 22, 2023

• Read More

Clinical Edge Journal Scan

Cumulative airborne dioxin exposure increases CLL and SLL risk

Publish date: October 22, 2023

• Read More

Clinical Edge Journal Scan

Ibrutinib and bortezomib combo durably effective in relapsed or refractory MCL with high-risk features

Publish date: October 22, 2023

• Read More

Clinical Edge Journal Scan

Ibrutinib maintenance after frontline induction is effective in mantle cell lymphoma

Publish date: October 22, 2023

• Read More

Clinical Edge Journal Scan

High-dose methotrexate does not reduce CNS progression risk in high-risk aggressive BCL

Publish date: October 22, 2023

• Read More

Pages

• « first
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• last »